Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Deniz Gursul won the Inez Oliver Prize for an outstanding essay on how brain imaging is used for measuring pain in babies, and how it can assist in developing pain relief measures.

Deniz Gursul, a DPhil researcher with the Paediatric Neuroimaging Group, studies how infants respond to necessary clinical procedures – e.g. blood tests, lumbar punctures, immunisations – and whether these responses can be modulated by potential analgesics.

The Inez Oliver Prize is awarded by St Cross College, which Deniz is a member of. The prize is presented to a St Cross student for producing an exceptional essay, “with a preference for a topic relating to a subject benefitting humanity in an innovative way”. Due to its nature, Deniz’s doctoral project fitted the theme perfectly.

“My research is unique, and it attracts a lot of public interest” says Deniz. “I am very pleased to work on a topic that is so clinically applicable.” Deniz applies electroencephalography (EEG), a non-invasive brain imaging technology, to monitor the brain activity of babies. EEG outputs can show patterns of brain activity specifically related to pain, and Deniz uses them to investigate the efficacy of potential analgesics. In particular, her work explores the effectiveness of non-pharmacological pain relief measures, such as gentle touch. Researching such methods is especially important in the case of infants, as non-pharmacological intervention is easy to implement and does not cause side effects.

In her winning essay, Deniz provides a historical perspective on the topic of infant pain, and details the current developments in the field, including her own research focus.

Apart from being a successful researcher, Deniz is also heavily involved in leadership and outreach work – she sits on the Paediatrics Graduate Studies Committee and the Events Committee, she co-organised the 2018 Medical Sciences Division Graduate Day, and she has presented her research at numerous events, including Cheltenham Science Festival. Deniz has also recently been awarded a grant to attend a conference on the study of pain in Boston. In her spare time, she enjoys dancing and Zumba.

The Inez Oliver Prize has been established thanks to a generous donation from Green Templeton College Alumnus Paul Oliver in honour of his wife Inez to celebrate their 30th Wedding Anniversary.

Similar stories

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Oxford Vaccine Group among winners at NHS Parliamentary awards

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.

Innovation award for Paediatrics researcher to develop new treatments for childhood cancer

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Professor Matthew Snape named NIHR Senior Investigator

Four academics supported by the NIHR Oxford Biomedical Research Centre have been awarded a prestigious national award, among them Matthew Snape from the Oxford Vaccine Group.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.